Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open Label, Phase I/II of Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype

NCT05230680 is registered in ClinicalTrials.gov with Won Seog Kim as lead sponsor.

NCT NCT05230680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05230680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open Label, Phase I/II of Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype
Lead sponsor
Won Seog Kim
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 1, 2022
Completion date
December 31, 2026
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

t cell lymphoma